Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/88496Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Mifsud, Janet | - |
| dc.contributor.author | Vella, T. | - |
| dc.contributor.author | Ellul-Micallef, Roger | - |
| dc.date.accessioned | 2022-02-08T07:39:58Z | - |
| dc.date.available | 2022-02-08T07:39:58Z | - |
| dc.date.issued | 2013-06 | - |
| dc.identifier.citation | Mifsud, J., Vella, T., & Ellul-Micallef, R. (2013). Antipsychotics and Aeds : therapeutic drug monitoring in a mental health care setting. Epilepsia, 54(s3), 62-63. | en_GB |
| dc.identifier.uri | https://www.um.edu.mt/library/oar/handle/123456789/88496 | - |
| dc.description.abstract | PURPOSE: A combination of valproate with an atypical antipsychotic provides synergistic mood stabilizing, anti-depressant and anti-psychotic action in bipolar and schizoaffective disorders. Reports of rare, but serious, adverse drug reactions occurring on the addition of valproate to olanzapine and quetiapine monotherapy indicate a possible drug-drug interaction (DDI). The aim of this study was thus to compare the plasma concentrations of quetiapine and olanzapine of patients concurrently taking valproate with that of patients on antipsychotic monotherapy. | en_GB |
| dc.description.abstract | METHOD: To achieve this aim, an HPLC-UV method for the analysis of quetiapine and olanzapine in human plasma was developed and used with a routine valproate therapeutic drug monitoring service. Bipolar disorder patients being treated with valproate/olanzapine, valproate/quetiapine or valproate/olanzapine/quetiapine monotherapy (controls) were recruited from mental health care setting. Plasma concentrations of the antipsychotics were measured and compared with those of patients not on the combination to assess the possible effect of valproate on quetiapine and olanzapine concentrations. | en_GB |
| dc.description.abstract | [excerpt] | en_GB |
| dc.language.iso | en | en_GB |
| dc.publisher | John Wiley & Sons, Inc. | en_GB |
| dc.rights | info:eu-repo/semantics/restrictedAccess | en_GB |
| dc.subject | Antipsychotic drugs | en_GB |
| dc.subject | Valproic acid | en_GB |
| dc.subject | Drug monitoring | en_GB |
| dc.subject | Manic-depressive illness -- Treatment | en_GB |
| dc.title | Antipsychotics and Aeds : therapeutic drug monitoring in a mental health care setting | en_GB |
| dc.type | article | en_GB |
| dc.rights.holder | The copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder. | en_GB |
| dc.bibliographicCitation.conferencename | 30th International Epilepsy Congress | en_GB |
| dc.bibliographicCitation.conferenceplace | Montreal, Canada, 23-27/06/2013 | en_GB |
| dc.description.reviewed | peer-reviewed | en_GB |
| dc.publication.title | Epilepsia | en_GB |
| Appears in Collections: | Scholarly Works - FacM&SCPT | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Antipsychotics and Aeds.pdf Restricted Access | 45.47 kB | Adobe PDF | View/Open Request a copy |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.